Calreticulin Is the Dominant Pro-Phagocytic Signal on Multiple Human Cancers and Is Counterbalanced by CD47

The hallmarks of cancer

Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219

Stem cells, cancer, and cancer stem cells

Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738

Identification of human brain tumour initiating cells

Singh, S. K., Hawkins, C. E., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., & Dirks, P. B. (2004) · Nature · doi:10.1038/nature03128 · Cited by 7,564

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

Lapidot, T., Sirard, C., Vormoor, J., Murdoch, B., Hoang, T., Caceres-Cortes, J., Minden, M., Paterson, B., Caligiuri, M. A., & Dick, J. E. (1994) · Nature · doi:10.1038/367645a0 · Cited by 4,783

Calreticulin exposure dictates the immunogenicity of cancer cell death

Obeid, M., Tesniere, A., Ghiringhelli, F., Fimia, G. M., Apetoh, L., Perfettini, J.-L., Castedo, M., Mignot, G., Panaretakis, T., Casares, N., et al. (2007) · Nature Medicine · doi:10.1038/nm1523 · Cited by 3,216

Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data

Dai, M. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni179 · Cited by 1,807

CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells

Majeti, R., Chao, M. P., Alizadeh, A. A., Pang, W. W., Jaiswal, S., Gibbs, K. D., van Rooijen, N., & Weissman, I. L. (2009) · Cell · doi:10.1016/j.cell.2009.05.045 · Cited by 1,752

CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis

Jaiswal, S., Jamieson, C. H. M., Pang, W. W., Park, C. Y., Chao, M. P., Majeti, R., Traver, D. J., van Rooijen, N., & Weissman, I. L. (2009) · Cell · doi:10.1016/j.cell.2009.05.046 · Cited by 1,578

A blast from the past: clearance of apoptotic cells regulates immune responses

Savill, J., Dransfield, I., Gregory, C. D., & Haslett, C. (2002) · Nature reviews. Immunology · doi:10.1038/nri957 · Cited by 1,574

Immune surveillance of tumors

Swann, J. B., & Smyth, M. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31405 · Cited by 1,518

Prospects of immune checkpoint blockade and vaccine-based immunotherapy for glioblastoma

Tietze, S., Michen, S., Schackert, G., & Temme, A. (2021) · Innovative Surgical Sciences · doi:10.1515/iss-2020-0034 · Cited by 4

Therapeutic Antibodies and Immunologic Conjugates

Dobrenkov, K., & Cheung, N. V. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-47674-4.00030-x · Cited by 4

Combining radiation with immune checkpoint inhibitors therapy for HCC: From the alteration of the immune microenvironment by radiotherapy

Zhou, K., Jiang, Y., Feng, S., Wang, T.-Y., Wang, L., Cao, J., & Jiao, Y. (2022) · Radiation Medicine and Protection · doi:10.1016/j.radmp.2022.07.005 · Cited by 4

3D culture boosting fullerenol nanoparticles to induce calreticulin exposure on MCF-7 cells for enhanced macrophage-mediated cell removal

Liu, S., Liang, H., Lv, L., Hu, F., Liu, Q., Wang, Y., Zhu, J., Chen, Z., Li, J., Wang, Z., et al. (2023) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2023.113204 · Cited by 4

Tuftsin-tailored fusion protein inhibits the growth of circulating gastric tumor cells associated with macrophage phagocytosis

Yuan, D., Zhai, X., Zhu, K., Ji, J., & Liu, W. (2023) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2023.101443 · Cited by 4

Targeting CD47 as a therapeutic strategy: A common bridge in the therapy of COVID-19-related cancers

Zandi, M., Shafaati, M., Shenagari, M., & Naziri, H. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e17959 · Cited by 4

Immunogenic cell death induced by low temperature plasma to activate antitumor immunity and enhance therapeutic efficiency

Wang, X., Wang, X., Liu, J.-R., Lu, J., Xu, G., Cui, Y., Shi, X., & Zhang, G. (2024) · Journal of Physics D Applied Physics · doi:10.1088/1361-6463/ad2832 · Cited by 4

Role of myeloid cells in the tumor microenvironment

Balakrishnan, A., Vig, M., & Dubey, S. (2022) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2022.33 · Cited by 4

The Central Role for Microenvironment in B-Cell Malignancies: Recent Insights into Synergistic Effects of its Therapeutic Targeting and Anti-CD20 Antibodies

Ahmadzadeh, V., Tofigh, R., Farajnia, S., & Pouladi, N. (2015) · International Reviews of Immunology · doi:10.3109/08830185.2015.1077830 · Cited by 4

Response: mechanisms of targeting CD47-SIRPα in hematologic malignancies

Chao, M. P., Majeti, R., & Weissman, I. L. (2012) · Blood · doi:10.1182/blood-2012-02-411249 · Cited by 4

Engineered CD47 protects T cells for enhanced antitumor immunityPreprint

Yamada‐Hunter, S. A., Theruvath, J. L., McIntosh, B. J., Freitas, K. A., Radosevich, M., Leruste, A., Dhingra, S., Martínez-Vélez, N., Xu, P., Delaidelli, A., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.20.545790 · Cited by 4

Development of aGD2–SIRPα Fusion Antibodies Targeting Neuroblastoma and the Innate Immune Checkpoint Receptor CD47

Schuurmans, F., Wittner, A., van den Bijgaart, R. J. E., Tahk, S., Boros, M. G. M., Looman, M. W. G., Fenn, N. C., Humpe, A., Hopfner, K., & Adema, G. J. (2025) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-24-1090 · Cited by 3

LMO7 Suppresses Tumor‐Associated Macrophage Phagocytosis of Tumor Cells Through Degradation of LRP1

Li, M., Wang, T., Zhong, Y., Wang, Z., Li, W., Wang, Z., Yang, X., Yu, Q., Xiang, J., Gu, W., et al. (2025) · Advanced Science · doi:10.1002/advs.202511162 · Cited by 3

Human Serum Albumin-Lipid Nanocapsules of Duvelisib for Hematological Cancers: Characterization, In-Vitro Cell-Culture, Toxicity and Pharmacokinetic Studies

Mahajan, S., Aalhate, M., Sharma, A., Karadagatla, S., Guru, S. K., & Singh, P. K. (2026) · AAPS PharmSciTech · doi:10.1208/s12249-025-03305-2 · Cited by 3

A logic-gated trispecific engager enhances macrophage killing of cancer cells in solid tumors

Zhao, X., Jing, W., Wang, G., Liu, Z., Xu, X., Han, M., Fu, Z., Zhang, Y., Zheng, Z., Zhang, J., et al. (2026) · Nature Biotechnology · doi:10.1038/s41587-026-03057-9 · Cited by 4

Danger or Salvation? The Role of DAMPs in Cancer Therapy

Vedunova, A. A., Guryev, E. L., Gudkov, S. V., Mishchenko, T. A., & Vedunova, M. V. (2026) · Cancers · doi:10.3390/cancers18091442 · Cited by 3

Radiotherapy and immunotherapy in cancer treatment: mechanisms of clinical synergy

Lu, L., & Deng, L. (2026) · Journal of Clinical Investigation · doi:10.1172/jci207550 · Cited by 3

The potential of biomimetic nanoparticles for macrophage repolarisation and phagocytosis in tumour immunotherapy

Sun, Z., Zhou, R., Liu, J., Zhao, Q., Sun, C., & Sun, Y. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.154506 · Cited by 3

Genotype-integrated single-cell transcriptome analysis reveals the role of DDX41 pR525H in a patient with myelodysplastic neoplasms

Matsui, H., Nagamachi, A., Koizumi, M., Kudo, R., Ajiro, M., Harada, H., Harada, Y., Shichino, S., & Yoshimi, A. (2025) · Scientific Reports · doi:10.1038/s41598-025-06477-w · Cited by 3

Harnessing the Tumor Microenvironment for the Treatment of Double Hit Lymphoma

Lossos, C., Liu, Y., Christie, A. L., Hemann, M. T., & Weinstock, D. M. (2016) · Blood · doi:10.1182/blood.v128.22.47.47 · Cited by 3

Oncolytic Viruses as Immunotherapeutic Agents

Trehub, Y., & Havrilov, A. (2020) · Springer eBooks · doi:10.1007/978-3-030-50287-4_27 · Cited by 3

Membrane Bound CRT Fragment Accelerates Tumor Growth of Melanoma B16 Cell In Vivo through Promoting M2 Polarization via TLR4

Wang, H.-M., Zhou, Z., Miao, J., Zhu, B., Dai, X., Zhong, Q., Gong, F., & Gao, X. (2022) · Journal of Immunology Research · doi:10.1155/2022/4626813 · Cited by 3

The Role of Intra-Tumor Hypoxia in Cancer Cells Immune Escape Mechanism

Farhangnia, P., Delbandi, A., Aghamohamadi, N., Safdarian, A. R., & Akbarpour, M. (2022) · Springer eBooks · doi:10.1007/978-3-030-80962-1_61-1 · Cited by 3

A novel anoikis-related gene signature identifies LYPD1 as a novel therapy target for bladder cancer

Song, Z., Gui, S., Xiao, S., Rao, X., Cong, N., Deng, H., Yu, Z., & Zeng, T. (2024) · Scientific Reports · doi:10.1038/s41598-024-53272-0 · Cited by 3

Therapeutic Targeting of TIM-4-L with Engineered T Cells for Acute Myeloid Leukemia

Cieniewicz, B., Oliveira, E., Saxton, M., Torabi, D., Bhatta, A., Kukutla, P., Arballo, A., Yang, Z., Yu, B., Fate, M., et al. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-3044 · Cited by 3

Proteomic Profiling of Lymph Nodes Differentiates Classic Hodgkin Lymphoma With and Without Skeletal Involvement

Andersen, M. D., Wolter, K., Enemark, M. H., Pedersen, M. A., Gormsen, L. C., Lauridsen, K. L., Starklint, J., Hamilton-Dutoit, S., d'Amore, F., Ludvigsen, M., et al. (2024) · European Journal of Haematology · doi:10.1111/ejh.14326 · Cited by 3

Stem Cells, Cell Differentiation, and Cancer

Dalerba, P. D., Clarke, M. F., Weissman, I. L., & Diehn, M. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-2865-7.00007-2 · Cited by 3

CALR and CD47: An Insight into Their Roles in the Disease Progression of MDS and MPN

Boasman, K., Simmonds, M. J., & Rinaldi, C. R. (2019) · Journal of Blood Disorders & Transfusion · doi:10.4172/2155-9864.1000413 · Cited by 3

Calreticulin in Essential Thrombocythemia: StressINg OUT the Megakaryocyte Nucleus

Iborra, F. J., & Papadopoulos, P. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00103 · Cited by 3

A novel biomarker of chronic allograft dysfunction in renal transplant recipients (serum calreticulin and CD47)

Gawish, R. I., Aggan, H. A. M. E., Mahmoud, S. A. H., & Mortada, S. A. M. (2020) · The Egyptian Journal of Internal Medicine · doi:10.1186/s43162-020-00018-9 · Cited by 3

[Effect of clinical pathways based on integrative medicine for patients with chronic heart failure: a multi-center research].

Zou, X., Pan, G., Sheng, X.-G., Yao, G., Zhu, M., Wu, Y., Chen, X., Wang, Y., Cui, J., & Chen, J.-D. (2013) · PubMed · Cited by 3

Characterization of a Novel Murine Colon Carcinoma Subline with High-Metastatic Activity Established by In Vivo Selection Method

Ma, L., Sakamoto, Y., Kanai, A., Otsuka, H., Takahashi, A., Kakimi, K., Imai, T., & Shimokawa, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082829 · Cited by 3

Hematopoietic Stem Cells, Regenerative Medicine, and Leukemogenesis

Weissman, I. L. (2015) · Wiley eBooks · doi:10.1002/9781118416426.ch4 · Cited by 3

Discovery of Anti‐CD47 Peptides as Innate Immune Checkpoint Inhibitors

Mustafa, B., Fetse, J., Kandel, S., Lin, C., Adhikary, P., Mamani, U., Liu, Y., Ibrahim, M. N., Alahmari, M., & Cheng, K. (2023) · Advanced Therapeutics · doi:10.1002/adtp.202300114 · Cited by 2

Paradoxical cell targeting of calreticulin-empowered, protein-only nanoparticles

Parladé, E., García‐León, A., Voltà‐Durán, E., Unzueta, U., Mangues, R., Casanova, I., Villaverde, A., & Vázquez, E. (2024) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2024.114410 · Cited by 2

Derivation of resident macrophages and construction of tumor microenvironment in Flk-1-knockout chimeric mice produced via blastocyst complementation

Ishii, S., Yamazaki, K., Li, P., Kubara, K., Ishizuka, Y., Izumi, Y., Kamisako, T., Ishizaki, H., Ono, Y., Mizuno, N., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-12571-w · Cited by 2

Advancements in Hematopoietic Stem Cell Therapy: From Biological Pathways to Emerging Therapeutic Strategies

Cortiana, V., Chorya, H. P., Abbas, R. H., Gambill, J. L., Theyver, A., Park, C. H., & Leyfman, Y. (2025) · Therapeutics · doi:10.3390/therapeutics2040018 · Cited by 2

CD47 signaling in aging and age-related diseases: mechanisms, challenges, and therapeutic opportunities

Menga, A. M., Hong, X., & Zhu, L. (2025) · Biogerontology · doi:10.1007/s10522-025-10370-4 · Cited by 3

Efferocytosis as a Metabolic Rheostat: The Metabolic Bridge connecting TKI-induced cell death to immune tolerance in hepatocellular carcinoma

Sheng, X., Wang, L., Shi, G., Li, Y., Wang, D., Wang, W., Du, Y., Wang, S., Mi, C., & Yang, H. (2026) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2026.105355 · Cited by 2

Magrolimab Plus Azacitidine Versus Placebo Plus Azacitidine in Patients With Untreated Higher-Risk Myelodysplastic Syndromes: The Phase III ENHANCE Study

Sallman, D. A., Garcia‐Manero, G., Daver, N. G., Abboud, C. N., Stein, E. M., Larkin, K. T. M., Halpern, A. B., McCurdy, S. R., Malki, M. M. A., Murthy, G. S. G., et al. (2026) · Journal of Clinical Oncology · doi:10.1200/jco-25-00617 · Cited by 2

Overexpress of CD47 does not alter the stemness of MCF-7 breast cancer cells

Nguyen, O. T.-K., Bui, A. N.-T., Vu, N. B., & Pham, P. V. (2016) · Biomedical Research and Therapy · doi:10.7603/s40730-016-0044-2 · Cited by 2

Role for phagocytosis in the prevention of neoplastic transformation in Drosophila

Zhang, M., Nagaosa, K., Nakai, Y., Yasugi, T., Kushihiki, M., Rahmatika, D., Sato, M., Shiratsuchi, A., & Nakanishi, Y. (2020) · Genes to Cells · doi:10.1111/gtc.12804 · Cited by 2

To eat, or not to eat, that is the question: Neural stem cells escape phagocytosis in autism with macrocephaly

Schafer, S. T., & Gage, F. H. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2104888118 · Cited by 2

Insights from Long Noncoding RNAs into Cancer-immunity Cycle Regulation

Liang, Y., Zhang, Y., Tan, X.-R., Qiao, H., Ma, J., Li, Y., & Liu, N. (2023) · Journal of Cancer Immunology · doi:10.33696/cancerimmunol.5.073 · Cited by 2

Anaplastic Lymphoma Kinase (ALK) Inhibitors Enhance Phagocytosis Induced by CD47 Blockade in Sensitive and Resistant ALK-Driven Malignancies

Malighetti, F., Villa, M., Mauri, M., Piane, S., Crippa, V., Crespiatico, I., Cocito, F., Bossi, E., Steidl, C., Civettini, I., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12122819 · Cited by 2

In vitro evaluation of the immunogenic potential of gramicidin S and its photocontrolled analogues

Horbatok, K., Semchuk, I., Gorbach, O. I., Khranovska, N., Kosach, V., Borysko, P., Koniev, S., Ulrich, A. S., Afonin, S., & Komarov, I. V. (2025) · RSC Medicinal Chemistry · doi:10.1039/d5md00075k · Cited by 2

SIRPαFc treatment targets human acute myeloid leukemia stem cells

Galkin, O., McLeod, J. L., Kennedy, J. A., Jin, L., Mbong, N., Wong, M., Uger, R. A., Minden, M. D., Danska, J. S., & Wang, J. C. Y. (2020) · Haematologica · doi:10.3324/haematol.2019.245167 · Cited by 2

Macrophage Differentiation and Activation States in the Tumor Microenvironment

Ginderachter, J. A. V. (2013) · Springer eBooks · doi:10.1007/978-94-007-6217-6_17 · Cited by 1

Cancer Stem Cells and the Microenvironment

Körkaya, H., Davis, A., & Wicha, M. S. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4066-6.00010-x · Cited by 2

Bladder cancer and relationship of cancer stem cell with recurrence

Özcan, Y., Çağlar, F., Altun, Z. S., & Aktaş, S. (2016) · The Anatolian Journal of General Medical Research · doi:10.5222/terh.2016.185 · Cited by 2

Comparative Proteomic Analysis of Breast Cancer Tissue and the Adjacent Normal Tissue in Iranian Patients with HER2 Negative Ductal Carcinoma of Breast

Shoar, M. A., Hosseini, M., Arianmanesh, M., Eghdam-Zamiri, R., Attarian, S., & Mellati, A. A. (2017) · International Journal of Cancer Management · doi:10.5812/ijcm.6019 · Cited by 2

Pharmacokinetics and Systems Pharmacology of Anti-CD47 Macrophage Immune Checkpoint Inhibitor Hu5F9-G4

Mishra, A., Kataria, I., & Nair, S. (2019) · Current pharmacogenomics and personalized medicine (Online)/Current pharmacogenomics and personalized medicine · doi:10.2174/1875692117666190820105134 · Cited by 2

Study on the significance correlation between CEBPA and Calreticulin at mRNA level diagnosed in de nevo AML patients

Salarpour, F., Goudarzipour, K., Mohammadi, M. H., Hajifathali, A., & Farsani, M. A. (2020) · Bangladesh Journal of Medical Science · doi:10.3329/bjms.v19i4.46633 · Cited by 2

Calreticulin – a multifaced protein

Kanduła, Z., & Lewandowski, K. C. (2021) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.5604/01.3001.0014.8892 · Cited by 2

Proteomic characterization of phagocytic primary human monocyte-derived macrophages

Volk, R. F., Montaño, J. L., Warrington, S. E., Hofmann, K. L., & Zaro, B. W. (2022) · RSC Chemical Biology · doi:10.1039/d2cb00076h · Cited by 2

Homozygous CALR Mutation in Primary Myelofibrosis and Its Effect on Disease Phenotype: A Case Report and Review of the Literature

Rizvi, Q., Zaidi, U., Shahid, S., Ahmed, S., & Shamsi, T. S. (2019) · Case Reports in Hematology · doi:10.1155/2019/1430170 · Cited by 2

Chromosomal instability can favor macrophage-mediated immune response and induce a broad, vaccination-like anti-tumor IgG responsePreprint

Hayes, B. H., Wang, M., Zhu, H., Phan, S. H., Dooling, L. J., Andrechak, J. C., Chang, A. H., Tobin, M. P., Ontko, N. M., Marchena, T., et al. (2024) · eLife · doi:10.7554/elife.88054.2 · Cited by 2

Anti-CD47 antibodies: A potential new cancer immunotherapy

Ou, D., Jian, C.-Z., Low, G.-S., & Lin, L. (2023) · Journal of Cancer Research and Practice · doi:10.4103/ejcrp.ejcrp-d-23-00006 · Cited by 1

Characterization of Pleural Mesothelioma by Hierarchical Clustering Analyses Using Immune Cells within Tumor Microenvironment

Inaguma, S., Wang, C., Ito, S., Ueki, A., Lasota, J. P., Czapiewski, P., Langfort, R., Ryś, J., Szpor, J., Waloszczyk, P., et al. (2024) · Pathobiology · doi:10.1159/000538520 · Cited by 1

Immune Stress-induced Tumor Mutation Burden and Neoantigen Expression in 4T1 Mammary Cancer Cells: A Potential Mechanism for Long-term Survival in Patients Treated With Immune Checkpoint Inhibitors

Ishiguro, T., TAKEDA, K., Takayanagi, D., Mura, E., Suzuki, R., Tsurui, T., Iriguchi, N., Hirasawa, Y., Ohkuma, R., Shimokawa, M., et al. (2024) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20481 · Cited by 1

In Situ Vaccination with a Vpr-Derived Peptide Elicits Systemic Antitumor Immunity by Improving Tumor Immunogenicity

Pan, D., Du, L., Liu, J., Kuerban, K., Huang, X., Wang, Y., Guo, Q., Chen, H., Wang, S., Wang, L., et al. (2025) · Vaccines · doi:10.3390/vaccines13070710 · Cited by 1

Roles of the phagocytosis checkpoint in radiotherapy

Kui, Y., Tong, F., Zhang, R., Wang, J., & Dong, X. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07921-5 · Cited by 1

CD47-SIRPα: A Pivotal Signaling Pathway for Targeting Immunotherapy in Non-Small Cell Lung Cancer

Zhang, L., Wu, X., Zhu, M., Zhou, Y., Liu, K., Lin, B., & Li, M. (2025) · Current Medicinal Chemistry · doi:10.2174/0109298673383976250911101532 · Cited by 1

The Role of Intra-tumor Hypoxia in Cancer Cells Immune Escape Mechanism

Farhangnia, P., Delbandi, A., Aghamohamadi, N., Safdarian, A. R., & Akbarpour, M. (2025) · Springer eBooks · doi:10.1007/978-3-032-00759-9_61 · Cited by 1

FACS-based genome-wide CRISPR screening platform identifies modulators of CD47

Yin, L., He, W., Wang, Y., Zhang, H., Huang, M., Yan, Y., Li, S. B., Feng, X., Sáenz, F., Zhang, J., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1684539 · Cited by 1

Construct Optimization Enables Oncolytic Virus-Mediated Functional Membrane Localization of Calreticulin and Macrophage Reprogramming

Zhang, X., Xiong, S., Zhang, S., Si, Y., Dai, Z., Ji, T., Huang, X., Chen, D., Li, F., Hu, F., et al. (2026) · Human Gene Therapy · doi:10.1177/10430342261423100 · Cited by 1

“AND” Logic-Gated Biomimetic Nanoparticles to Activate Macrophage Phagocytosis for Cancer Immunotherapy

Zhang, T., Luo, J.-Q., Liu, Y., Yu, H.-H., Zhang, X., Zhuang, Z.-H., Rao, L., & Du, J. (2026) · Nano Letters · doi:10.1021/acs.nanolett.5c05413 · Cited by 1

A viral ORFeome library for systems-level genetic dissection of host-pathogen interactions

Fujimura, E., O'Leary, C. N., Li, M. Z., Roberts, R. A., Glassman, C. R., Paulo, J. A., Jiang, H., Abdelfattah, N. S., Wooten, E. C., Mirman, Z., et al. (2026) · Cell · doi:10.1016/j.cell.2026.05.024 · Cited by 3

CD47/SIRPα axis in cancer immunotherapy: Mechanisms, regulation, and therapeutic strategies

Li, Y. D., Yu, H., Shi, J., Hou, Y., & Qian, G. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.179122 · Cited by 1

Immunotherapeutic targeting of calreticulin mutant myeloproliferative neoplasms

Hertz, C., Spyrou, N., Hoffman, R., Bozkus, C. C., Bhardwaj, N., Tremblay, D. A., Kremyanskaya, M., & Mascarenhas, J. O. (2026) · Leukemia · doi:10.1038/s41375-026-03115-w · Cited by 2

CD4 T cells convert transient responses to KRAS inhibition to durable remissions in pancreatic cancer

Li, Q., Hoffman, M. T., Chun, J.-H., Parent, B. D., Hambitzer, F., Peprah, F., Kureshi, C. T. S., Lim, B. S., Chang, E., Walsh, M. J., et al. (2026) · Cell · doi:10.1016/j.cell.2026.08.045 · Cited by 1

Magnetically Guided Macrophage Immunobots Coordinate Iron‐Metabolic Cascades and Immunogenic Ferroptosis for Tumor Immunotherapy

Zeng, X., Zhang, Y., Wu, C., Duan, Q., Fan, M., Wang, K., Cai, S., & Yasa, I. C. (2026) · Advanced Science · doi:10.1002/advs.77760 · Cited by 1

Myelomonocytic Subsets in Tumor Microenvironment

Ginderachter, J. A. V. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1311-4_19 · Cited by 1

Role of Innate Immunity in Cancers and Antitumor Response

Jinushi, M., & Baghdadi, M. (2014) · Springer eBooks · doi:10.1007/978-3-662-44006-3_3 · Cited by 1

Thrombospondin-1 and Inhibition of Tumor Growth

Jeong, G. (2015) · Korean Journal of Physical Anthropology · doi:10.11637/kjpa.2015.28.4.175 · Cited by 2

Outside the Endoplasmic Reticulum: Non-Canonical GRP78 Signaling

Cook, K. L. (2019) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-030-05067-2_9 · Cited by 1

Cellular Indoctrination: How the Tumor Microenvironment Reeducates Macrophages Towards Nefarious Ends

Powers, A. A., Eisenberg, S. H., Jones, K. E., Stabile, L. P., Lotze, M. T., Dhupar, R., & Soloff, A. C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00084-0 · Cited by 1

Calreticulin in Myeloproliferative Neoplasms: The Other Side of the Alice Mirror

Varricchio, L., & Migliaccio, A. R. (2014) · EMJ Hematology · doi:10.33590/emjhematol/10313345 · Cited by 1

Breaking the ‘don’t eat me’ signal: in silico design of CD47-directed peptides for cancer immunotherapy

Laddha, K., & Sobhia, M. E. (2023) · Molecular Diversity · doi:10.1007/s11030-023-10732-5 · Cited by 1

SMAC mimetics induce human macrophages to phagocytose live cancer cells

Liu, S. Y., Hulsman, M. P. M., Leyendecker, P., Chang, E., Donovan, K. A., Strobel, F., Dougan, J., Fischer, E. S., Dougan, M. L., Dougan, S. K., et al. (2024) · Immunotherapy Advances · doi:10.1093/immadv/ltaf026 · Cited by 1

Miscellaneous Approaches and Considerations: TLR Agonists and Other Inflammatory Agents, Anti-Chemokine Agents, Infectious Agents, Tumor Stroma Targeting, Age and Sex Effects, and Miscellaneous Small Molecules

Svatek, R. S., & Curiel, T. J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4732-0_13 · Cited by 1

Relationship Between Immunohistochemical Expression Level of CD47 and Pathological Disease Stage in Prostate Adenocarcinoma

Doğan, S., Bağrıaçık, E. Ü., Sakaoğulları, Ş. Z., Taştemur, S., & Odabaş, Ö. (2021) · Journal of Urological Surgery · doi:10.4274/jus.galenos.2021.2020.0035 · Cited by 1

Prevalence of JAK2V617F, CALR in Philadelphia Positive and Negative Myeloproliferative Neoplasm

Abedi, E., Karimi, M., Cohan, N., Haghpanah, S., Yaghobi, R., Azarpira, N., Moghadam, M., Bayat, E., Farokhian, F., Mohammadi, H., et al. (2021) · Galen Medical Journal · doi:10.31661/gmj.v10i0.2127 · Cited by 1

Induction of Immunogenic Cell Death by Chemotherapeutic Platinum Complexes

Wong, D. Y. Q. (2018) · Springer theses · doi:10.1007/978-981-10-8594-9_6 · Cited by 1

Prevalence of JAK2V617F, CALR in Philadelphia Positive and Negative Myeloproliferative Neoplasm

Ramzi, M., Abedi, E., Karimi, M., Cohan, N., Haghpanah, S., Yaghobi, R., Azarpira, N., Moghadam, M., Bayat, E., Farokhian, F., et al. (2021) · Galen Medical Journal · doi:10.31661/gmj.v10i.2127 · Cited by 1

Strategies of Mycoplasma ovipneumoniae to evade immune clearance by alveolar macrophagesPreprint

Gao, L., Zhang, K., Zhang, Y., Ma, C., Zhou, X.-Y., & Li, M. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.28.450257 · Cited by 1

Calreticulin

Dudek, E., & Michalak, M. (2017) · Springer eBooks · doi:10.1007/978-3-319-67199-4_101570 · Cited by 1

Calreticulin

Dudek, E., & Michalak, M. (2016) · Springer eBooks · doi:10.1007/978-1-4614-6438-9_101570-1 · Cited by 1

Phagocytic Synapses

Goodridge, H. S., & Hassanzadeh‐Kiabi, N. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-394447-4.30105-5 · Cited by 1

Chromosomal instability can favor macrophage-mediated immune response and induce a broad, vaccination-like anti-tumor IgG responsePreprint

Hayes, B. H., Wang, M., Zhu, H., Phan, S. H., Dooling, L. J., Andrechak, J. C., Chang, A. H., Tobin, M. P., Ontko, N. M., Marchena, T., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.02.535275 · Cited by 1

Chromosomal instability can favor macrophage-mediated immune response and induce a broad, vaccination-like anti-tumor IgG responsePreprint

Hayes, B. H., Wang, M., Zhu, H., Phan, S. H., Andrechak, J. C., Chang, A. H., Dooling, L. J., Tobin, M. P., Marchena, T., & Discher, D. E. (2023) · eLife · doi:10.7554/elife.88054.1 · Cited by 1

Surface Modification of Extracellular Vesicles with Polyoxazolines for Enhanced Plasma Stability and Tumor AccumulationPreprint

Simon, L., Constanzo, J., Benkhaled, B. T., Terraza‐Aguirre, C., Berthelot, J., Pednekar, K. P., Clark, K. C., Emerson, S. J., Atis, S., Elfekih, Z. I., et al. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4826812 · Cited by 1

Isoform switch of CD47 provokes macrophage-mediated pyroptosis in ovarian cancerPreprint

Wang, Z., Yang, L., Yang, S., Li, G., Xu, M., Kong, B., Shao, C., & Liu, Z. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.17.649282 · Cited by 1

TREM2 macrophages are associated with enhanced response to PD-1 blockade in human hepatocellular carcinomaPreprint

Hamon, P., Park, M. D., Bérichel, J. L., Cohen, M., Soong, B. Y., Buckup, M., Hennequin, C., Lindblad, K. E., Mattiuz, R., Figueiredo, I., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.09.675071 · Cited by 1

Caractérisation de la mort cellulaire induite par un anticorps trifonctionnel

Goèré, D. (2013) · theses.fr (ABES) · doi:10.70675/2c74e5c1z0324z498cz8affzb8a399d4f9a1

Quantification de la charge allélique des mutations de CALR sur ADN et sur ARN par analyse de fragments

Mansier, O. (2014) · HAL

Impacts of endoplasmic reticulum stress on calreticulin secretion and innate immunity

Peters, L. R. (2011) · Deep Blue (University of Michigan)

The Sixth Annual Translational Stem Cell Research Conference of the New York Stem Cell Foundation

Marshall, C. J., Hua, H., Shang, L., Ding, B., Zito, G., de Peppo, G. M., Wang, G. K., Douvaras, P., Sproul, A. A., Paull, D. J., et al. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06481.x

Combined chemotherapy and immunotherapy against experimental malignant brain tumors

Fritzell, S. (2013) · Lund University Publications (Lund University)

Programmed cell removal biomarkers calreticulin and CD 47 implicated in oral lichen planus

Allon, I., Vered, H., & Hirshberg, A. (2015) · Oral Diseases · doi:10.1111/odi.12361

Macrophages eat cancer cells using their own calreticulin as a guide: Roles of TLR and Btk

Feng, M., Chen, J. Y., Weissman-Tsukamoto, R., Volkmer, J.-P., Ho, P. Y., McKenna, K. M., Cheshier, S. H., Zhang, M., Ring, N. G., Gip, P., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424907112 · Cited by 253

The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors

Willingham, S. B., Volkmer, J.-P., Gentles, A. J., Sahoo, D., Dalerba, P. D., Mitra, S. S., Wang, J., Contreras-Trujillo, H., Martin, R. K., Cohen, J. D., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121623109 · Cited by 1,706

A Calreticulin Tail: C-terminal Mutants of Calreticulin Allow Cancer Cells to Evade Phagocytosis

Kaur, A., & Raghavan, M. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.01.024 · Cited by 5

CD47 masks pro-phagocytic ligands in cis on tumor cells to suppress antitumor immunity

Tang, Z.-H., Zhong, M., Qian, J., Galindo, C. C., Davidson, D., Li, J., Zhao, Y., Hui, E., & Veillette, A. (2023) · Nature Immunology · doi:10.1038/s41590-023-01671-2 · Cited by 66

The Macrophage ‘Do not eat me’ signal, CD47, is a clinically validated cancer immunotherapy target

Takimoto, C. H. M., Chao, M. P., Gibbs, C., Mccamish, M. A., Liu, J., Chen, J. Y., Majeti, R., & Weissman, I. L. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz006 · Cited by 128